Patent · US Active

Antibody to secreted polypeptide

US8889833B2 · kind B2 · utility

3Cited by

21References

12Claims

0Family size

Assignee

Incyte Corporation · US

Inventors

Henry Yue · Sunnyvale, US
Monique Yao · Mountain View, US
Ameena Gandhi · San Francisco, US
Mariah Baughn · San Jose, US
Anita Swarnakar · San Francisco, US
Narinder Walia · Merced, US
Madhusudan Sanjanwala · Los Altos, US
Michael Thorton · Oakland, US
Vicki S. Elliott Kaulback · Brentwood, US
Yan Lu · Mountain View, US
Kimberly Gietzen · San Diego, US
Neil Burford · Durham, US
Li Ding · Creve Coeur, US
April Hafalia · Pacifica, US
Y. Tang · Sunnyvale, US
Olga Bandman · Mountain View, US
Bridget Warren · Cupertino, US
Cynthia Honchell · Redwood City, US
Dyung Lu · San Jose, US
Kavitha Thangaveln · Santa Clara, US
Sally Lee · San Francisco, US
Yuming Xu · Mountain View, US
Junming Yang · San Jose, US
Preeti Lal · Sunnyvale, US
Bao Tran · Santa Clara, US
Craig Ison · San Jose, US
Brendan Duggan · Sunnyvale, US
Stephanie Kareht · San Jose, US

Key dates

Filing date	Oct 8, 2013
Grant date	Nov 18, 2014
Priority date	—
Expiry date	Oct 8, 2033

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC07K2317/76
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

The invention provides human secreted proteins (SECP) and polynucleotides which identify and encode SECP. The invention also provides expression vectors, host cells, antibodies, agonists, and antagonists. The invention also provides methods for diagnosing, treating, or preventing disorders associated with aberrant expression of SECP.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.